// App-Quantinova.ai

944 : Sharp Anti-HLA Antibody Development Due to Concomitant Graft Nephrectomy and Immunosuppression Withdrawal After Early Graft Loss

Researchers

Presenter

  • R. Valero

Principal Investigators

  • A. Aguilera

  • E. Rodrigo

  • D. San Segundo

  • M. Lopez-Hoyos

  • J. Ruiz

Medical Centers

  • Hematology, Hospital Universitario Marques de Valdecilla, Santander, Spain

  • Hematology, Hospital Universitario Marques de Valdecilla, Santander, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

Biomarkers

  • Plasma Renin Activity

Drug/Treatment

  • Mycophenolic acid

  • Tacrolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved